Cellular Engineering Technologies, Inc. (CET) provides high-value reagents and human cell lines that address the technical challenges of developing next-generation cell therapies and regenerative medicines. We offer human recombinant proteins and cytokines designed to generate maximum cellular response and bioavailability in cell culture. Our portfolio of normal and disease-model induced pluripotent stem cells (iPSCs), programmed using our patented episomal-based method, are the safest starting cell line for your research needs. Contact us today to discuss how our products and custom solutions can accelerate your research or IND-enabling activities.